Annual Operating Margin
-33.97%
+19.35%+36.29%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual operating profit margin is -33.97%, with the most recent change of +19.35% (+36.29%) on December 1, 2023.
- During the last 3 years, NBY annual operating margin has risen by +30.72% (+47.49%).
- NBY annual operating margin is now -294.45% below its all-time high of 17.47%, reached on December 31, 2009.
Performance
NBY Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-43.47%
+0.41%+0.93%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly operating profit margin is -43.47%, with the most recent change of +0.41% (+0.93%) on September 1, 2024.
- Over the past year, NBY quarterly operating margin has dropped by -15.34% (-54.53%).
- NBY quarterly operating margin is now -194.81% below its all-time high of 45.85%, reached on December 31, 2009.
Performance
NBY Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
NBY Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.3% | -54.5% |
| 3 y3 years | +47.5% | -46.2% |
| 5 y5 years | +46.0% | -46.2% |
NBY Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.9% | -264.1% | +56.8% |
| 5 y | 5-year | at high | +76.2% | -264.1% | +66.9% |
| alltime | all time | -294.4% | +97.9% | -194.8% | +98.6% |
NovaBay Pharmaceuticals Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -43.47%(-0.9%) |
| Jun 2024 | - | -43.88%(-26.5%) |
| Mar 2024 | - | -59.71%(+99.3%) |
| Dec 2023 | -33.97%(-36.3%) | -29.96%(+6.5%) |
| Sep 2023 | - | -28.13%(-5.4%) |
| Jun 2023 | - | -29.74%(-48.3%) |
| Mar 2023 | - | -57.50%(-22.1%) |
| Dec 2022 | -53.32%(-38.6%) | -73.81%(+518.2%) |
| Sep 2022 | - | -11.94%(-79.7%) |
| Jun 2022 | - | -58.77%(-19.2%) |
| Mar 2022 | - | -72.78%(-27.7%) |
| Dec 2021 | -86.85%(+34.3%) | -100.66%(-0.4%) |
| Sep 2021 | - | -101.06%(+16.0%) |
| Jun 2021 | - | -87.15%(+3.6%) |
| Mar 2021 | - | -84.12%(-9.7%) |
| Dec 2020 | -64.69%(-54.6%) | -93.11%(-2.0%) |
| Sep 2020 | - | -95.02%(+253.5%) |
| Jun 2020 | - | -26.88%(-66.9%) |
| Mar 2020 | - | -81.13%(-38.2%) |
| Dec 2019 | -142.45%(+126.4%) | -131.34%(+23.9%) |
| Sep 2019 | - | -106.01%(+37.5%) |
| Jun 2019 | - | -77.08%(-71.8%) |
| Mar 2019 | - | -273.04%(+514.4%) |
| Dec 2018 | -62.93%(+56.9%) | -44.44%(-22.8%) |
| Sep 2018 | - | -57.57%(-22.8%) |
| Jun 2018 | - | -74.55%(-7.2%) |
| Mar 2018 | - | -80.35%(-1393.9%) |
| Dec 2017 | -40.10%(-56.6%) | 6.21%(-111.7%) |
| Sep 2017 | - | -53.02%(+24.4%) |
| Jun 2017 | - | -42.62%(-58.2%) |
| Mar 2017 | - | -102.05%(+105.0%) |
| Dec 2016 | -92.31%(-80.9%) | -49.79%(-16.9%) |
| Sep 2016 | - | -59.95%(-28.7%) |
| Jun 2016 | - | -84.12%(-68.9%) |
| Mar 2016 | - | -270.56%(-29.4%) |
| Dec 2015 | -482.47% | -383.43%(-14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -445.67%(-7.5%) |
| Jun 2015 | - | -482.04%(-44.4%) |
| Mar 2015 | - | -866.36%(-13.7%) |
| Dec 2014 | -1603.80%(+260.1%) | -1003.46%(-62.9%) |
| Sep 2014 | - | -2705.92%(-12.1%) |
| Jun 2014 | - | -3078.05%(+117.4%) |
| Mar 2014 | - | -1415.97%(+48.4%) |
| Dec 2013 | -445.38%(+272.4%) | -954.12%(+251.6%) |
| Sep 2013 | - | -271.34%(-44.6%) |
| Jun 2013 | - | -489.39%(+43.2%) |
| Mar 2013 | - | -341.86%(+33.9%) |
| Dec 2012 | -119.61%(+205.0%) | -255.35%(+8674.9%) |
| Sep 2012 | - | -2.91%(-99.1%) |
| Jun 2012 | - | -330.08%(+75.3%) |
| Mar 2012 | - | -188.26%(-6.2%) |
| Dec 2011 | -39.21%(-15.3%) | -200.65%(+1498.8%) |
| Sep 2011 | - | -12.55%(-229.1%) |
| Jun 2011 | - | 9.72%(-112.4%) |
| Mar 2011 | - | -78.11%(+3844.9%) |
| Dec 2010 | -46.30%(-365.0%) | -1.98%(-97.5%) |
| Sep 2010 | - | -78.91%(+68.7%) |
| Jun 2010 | - | -46.78%(-39.7%) |
| Mar 2010 | - | -77.64%(-269.3%) |
| Dec 2009 | 17.47%(-113.8%) | 45.85%(-1761.2%) |
| Sep 2009 | - | -2.76%(-76.6%) |
| Jun 2009 | - | -11.79%(-6.4%) |
| Mar 2009 | - | -12.60%(-82.7%) |
| Dec 2008 | -126.58%(+27.4%) | -72.81%(-26.0%) |
| Sep 2008 | - | -98.37%(-43.4%) |
| Jun 2008 | - | -173.65%(-8.7%) |
| Mar 2008 | - | -190.28%(+85.2%) |
| Dec 2007 | -99.37%(-72.4%) | -102.76%(-8.9%) |
| Sep 2007 | - | -112.74%(-1.1%) |
| Jun 2007 | - | -113.99%(+66.6%) |
| Mar 2007 | - | -68.44%(-84.2%) |
| Dec 2006 | -360.47% | -432.75% |
FAQ
- What is NovaBay Pharmaceuticals annual operating profit margin?
- What is the all time high annual operating margin for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual operating margin year-on-year change?
- What is NovaBay Pharmaceuticals quarterly operating profit margin?
- What is the all time high quarterly operating margin for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly operating margin year-on-year change?
What is NovaBay Pharmaceuticals annual operating profit margin?
The current annual operating margin of NBY is -33.97%
What is the all time high annual operating margin for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual operating profit margin is 17.47%
What is NovaBay Pharmaceuticals annual operating margin year-on-year change?
Over the past year, NBY annual operating profit margin has changed by +19.35% (+36.29%)
What is NovaBay Pharmaceuticals quarterly operating profit margin?
The current quarterly operating margin of NBY is -43.47%
What is the all time high quarterly operating margin for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly operating profit margin is 45.85%
What is NovaBay Pharmaceuticals quarterly operating margin year-on-year change?
Over the past year, NBY quarterly operating profit margin has changed by -15.34% (-54.53%)